Active Ingredient History
Tariquidar (INN/USAN) is a P-glycoprotein inhibitor undergoing research as an adjuvant against multidrug resistance in cancer. Wikipedia
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Adrenal Cortex Neoplasms (Phase 2)
Adrenal Gland Neoplasms (Phase 1)
Breast Neoplasms (Phase 1)
Carcinoma, Non-Small-Cell Lung (Phase 3)
Kidney Neoplasms (Phase 2)
Lung Neoplasms (Phase 2)
Neoplasms (Phase 2)
Neuralgia (Phase 1/Phase 2)
Ovarian Neoplasms (Phase 2)
Sarcoma (Phase 1)
Uterine Cervical Neoplasms (Phase 2)
Wilms Tumor (Phase 1)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue